Todd C. Davis - Dec 13, 2024 Form 3 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
Director
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
Stock symbol
PVLA
Transactions as of
Dec 13, 2024
Transactions value $
$0
Form type
3
Date filed
12/16/2024, 07:41 PM
Previous filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PVLA Common Stock 113K Dec 13, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PVLA Stock Option (right to buy) Dec 13, 2024 Common Stock 4.64K $7.14 Direct F1
holding PVLA Stock Option (right to buy) Dec 13, 2024 Common Stock 11.5K $7.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.
F2 The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on May 28, 2024.